Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Scatton

Showing results (251-260 of 254) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 254 results.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptorsG Griebel, G Perrault, J Simiand, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2004
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profileN Aubin, P Barneoud, C Carter, et al.
Neuroscience|August 12, 2008
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profileY Claustre, M Leonetti, V Santucci, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Pageof 26

Showing results (251-260 of 254) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 254 results.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptorsG Griebel, G Perrault, J Simiand, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2004
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profileN Aubin, P Barneoud, C Carter, et al.
Neuroscience|August 12, 2008
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profileY Claustre, M Leonetti, V Santucci, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Pageof 26